Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -73 | N/A | N/A | N/A |
| Depreciation Amortization | N/A | 1 | N/A | N/A | N/A |
| Accounts receivable | N/A | -2 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 2 | N/A | N/A | N/A |
| Other Working Capital | N/A | 1 | N/A | N/A | N/A |
| Other Operating Activity | -6 | 40 | -26 | -21 | -10 |
| Operating Cash Flow | $-6 | $-30 | $-26 | $-21 | $-10 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4 | N/A | N/A | N/A |
| Debt Repayment | -6 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 17 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $11 | $4 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1 | 27 | 27 | 27 | 27 |
| End Cash Position | 5 | 1 | 1 | 6 | 17 |
| Net Cash Flow | $5 | $-26 | $-26 | $-21 | $-10 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6 | -30 | -26 | -21 | -10 |
| Free Cash Flow | -6 | -30 | -26 | -21 | -10 |